-
1Academic Journal
المؤلفون: Kiladjian J. -J., Zachee P., Hino M., Pane F., Masszi T., Harrison C. N., Mesa R., Miller C. B., Passamonti F., Durrant S., Griesshammer M., Kirito K., Besses C., Moiraghi B., Rumi E., Rosti V., Blau I. W., Francillard N., Dong T., Wroclawska M., Vannucchi A. M., Verstovsek S.
المساهمون: J.-. Kiladjian, P. Zachee, M. Hino, F. Pane, T. Masszi, C.N. Harrison, R. Mesa, C.B. Miller, F. Passamonti, S. Durrant, M. Griesshammer, K. Kirito, C. Besse, B. Moiraghi, E. Rumi, V. Rosti, I.W. Blau, N. Francillard, T. Dong, M. Wroclawska, A.M. Vannucchi, S. Verstovsek
مصطلحات موضوعية: Settore MED/15 - Malattie del Sangue
Relation: info:eu-repo/semantics/altIdentifier/pmid/31982039; info:eu-repo/semantics/altIdentifier/wos/WOS:000515522000016; volume:7; issue:3; firstpage:e226; lastpage:e237; numberofpages:12; journal:THE LANCET. HAEMATOLOGY; https://hdl.handle.net/2434/998568; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079894730
الاتاحة: https://hdl.handle.net/2434/998568
https://doi.org/10.1016/S2352-3026(19)30207-8 -
2Academic Journal
المؤلفون: Vannucchi, AM, te Boekhorst, Peter, Harrison, CN, He, GS, Caramella, M, Niederwieser, D, Boyer-Perrard, F, Duan, MH, Francillard, N, Molloy, B, Wroclawska, M, Gisslinger, H
المصدر: Vannucchi , AM , te Boekhorst , P , Harrison , CN , He , GS , Caramella , M , Niederwieser , D , Boyer-Perrard , F , Duan , MH , Francillard , N , Molloy , B , Wroclawska , M & Gisslinger , H 2019 , ' EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis ' , Haematologica , vol. 104 , no. 5 , pp. 947-954 . https://doi.org/10.3324/haematol.2018.204602
مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM024104, name=EMC MM-02-41-04
وصف الملف: application/pdf
-
3Academic Journal
المؤلفون: Verstovsek, S., Vannucchi, A. M., Griesshammer, M., Masszi, T., Durrant, S., PASSAMONTI, FRANCESCO, Harrison, C. N., Pane, F., Zachee, P., Kirito, K., Besses, C., Hino, M., Moiraghi, B., Miller, C. B., Cazzola, M., Rosti, V., Blau, I., Mesa, R., Jones, M. M., Zhen, H., Li, J., Francillard, N., Habr, D., Kiladjian, J. J.
المساهمون: S. Verstovsek, A.M. Vannucchi, M. Griesshammer, T. Masszi, S. Durrant, F. Passamonti, C.N. Harrison, F. Pane, P. Zachee, K. Kirito, C. Besse, M. Hino, B. Moiraghi, C.B. Miller, M. Cazzola, V. Rosti, I. Blau, R. Mesa, M.M. Jone, H. Zhen, J. Li, N. Francillard, D. Habr, J.J. Kiladjian
مصطلحات موضوعية: Settore MED/15 - Malattie del Sangue
Relation: info:eu-repo/semantics/altIdentifier/pmid/27102499; info:eu-repo/semantics/altIdentifier/wos/WOS:000379481500018; volume:101; issue:7; firstpage:821; lastpage:829; numberofpages:9; journal:HAEMATOLOGICA; https://hdl.handle.net/2434/996613; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84977123244
-
4Electronic Resource
-
5
المؤلفون: Elisa Rumi, Tamás Masszi, Ruben A. Mesa, Jean-Jacques Kiladjian, Francesco Passamonti, Tuochuan Dong, Nathalie Francillard, Vittorio Rosti, Srdan Verstovsek, Beatriz Moiraghi, Carlos Besses, Simon Durrant, Masayuki Hino, Pierre Zachee, Fabrizio Pane, Claire N. Harrison, Martin Griesshammer, Alessandro M. Vannucchi, Monika Wroclawska, Keita Kirito, Carole B. Miller, Igor Wolfgang Blau
المساهمون: Kiladjian, J. -J., Zachee, P., Hino, M., Pane, F., Masszi, T., Harrison, C. N., Mesa, R., Miller, C. B., Passamonti, F., Durrant, S., Griesshammer, M., Kirito, K., Besses, C., Moiraghi, B., Rumi, E., Rosti, V., Blau, I. W., Francillard, N., Dong, T., Wroclawska, M., Vannucchi, A. M., Verstovsek, S.
المصدر: Lancet Haematol
مصطلحات موضوعية: Ruxolitinib, Time Factors, Polyethylene Glycol, Polyethylene Glycols, 0302 clinical medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Hydroxyurea, Medicine, Polycythemia Vera, education.field_of_study, Fibrinolytic Agent, Pipobroman, Hematology, Recombinant Protein, Prognosis, Recombinant Proteins, Survival Rate, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Human, medicine.drug, medicine.medical_specialty, Polycythaemia, Prognosi, Population, Interferon alpha-2, Antiviral Agents, Article, Follow-Up Studie, 03 medical and health sciences, Pharmacotherapy, Fibrinolytic Agents, Internal medicine, Nitriles, Humans, Adverse effect, education, Survival rate, Antiviral Agent, Antineoplastic Combined Chemotherapy Protocol, business.industry, Quinazoline, Interferon-alpha, Anagrelide, medicine.disease, Pyrimidines, Pyrazole, Quinazolines, Pyrazoles, business, Follow-Up Studies, 030215 immunology